US Edition
Published • loading... • Updated
PEAK ASSET: ARVO WRAP 18 February: ASX closes up after NAB’s best day since April; Capstone sinks | Emerging markets set to outperform in 2026 | Cyclopharm Secures NIH Approval for Technegas, Boosting US Expansion | - Opening Print
Summary by MrTopStep.com LLC
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PEAK ASSET: ARVO WRAP 18 February: ASX closes up after NAB’s best day since April; Capstone sinks | Emerging markets set to outperform in 2026 | Cyclopharm Secures NIH Approval for Technegas, Boosting US Expansion | - Opening Print
18 February, 2026 Ever wonder what billionaires are worried about? See ‘pic of the day’ below! Across Markets… The Australian sharemarket climbed for a third consecutive session on Wednesday led by a rally in financials after National Australia Bank hit a record high on stronger-than-expected first-quarter results. The S&P/ASX 200 rose 0.5 per cent, or 48.10 points, to 9007, with materials the only sector of the 11 industry group to not finish…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
